Protein Tyrosine Phosphatase 1B

Slides:



Advertisements
Similar presentations
Lipid Metabolism 2: Acetyl-CoA carboxylase, fatty acid synthase reaction, and regulation of fatty acid synthesis Bioc 460 Spring Lecture 36 (Miesfeld)
Advertisements

Chapter 16 (Part 3) Fatty acid Synthesis.
REGULATION OF ACETYL CoA PROCESSING BIOC 460 DR. TISCHLER LECTURE 37.
Chapter 9. Regulation of Metabolism Regulation of metabolisms can be at different levels: Systemic level: neuro-hormone regulation Cell level: induction.
Ch. 33 Synthesis of Fatty acids, Triacylglycerols, Membrane lipids:
Ch 9. Lipotoxicity 정혜승. Introduction Definition of lipotoxicity : excess TG in nonadipocytes(=steatosis) → adverse effects on function or.
CHAPTER 13 Insulin Signaling. Figure 13.1 – General mechanism of signal transduction across a membrane Steps involved: 1. Release of primary messenger.
Chapter 5.
JAK-STAT Signaling Pathway.
Lecture 12 Fatty Acyl Synthase and Pentose Phosphate Pathway.
Fatty Acid Metabolism 1. Fatty acid synthesis.
Hormonal regulation of lipid metabolism
OXIDATION OF FATTY ACIDS
METABOLISM OF LIPIDS: SYNTHESIS OF FATTY ACIDS
Normal And Abnormal Cardiac Muscle Metabolism
Volume 52, Issue 3, Pages (March 2010)
Trachealess—A New Transcription Factor Target for PKB/Akt
Volume 142, Issue 6, Pages (May 2012)
AMPK is activated by HCMV; inhibition of the kinase blocks the glycolytic activation that is normally induced by infection and markedly reduces the production.
Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1  Krishna K. Singh, PhD, Praphulla C. Shukla, PhD,
Figure 3 Candidate signalling pathways of irisin in hepatocytes
Omega 3 – Omega 6: What is right for the liver?
دکتر مجیری داروساز متخصص فارماکولوژی
Endoplasmic reticulum stress in liver disease
Volume 134, Issue 2, Pages (February 2008)
eCB pathways involved in obesity-/HFD-associated CKD
NASH: a mitochondrial disease
Volume 11, Issue 5, Pages (May 2010)
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
Vascular dysfunction in diabetes mellitus
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
ACSF3 and Mal(onate)-Adapted Mitochondria
Cellular mechanisms of acute versus delayed preconditioning
The Ying and Yang of Bacterial Signaling in Necrotizing Enterocolitis
Figure 4 Mechanisms of leptin function on kidney injury
Cristoforo Silvestri, Vincenzo Di Marzo  Cell Metabolism 
The Hypoxic Response: Huffing and HIFing
Volume 134, Issue 4, Pages (April 2008)
Sweet Sixteenth for ChREBP: Established Roles and Future Goals
Selective Insulin and Leptin Resistance in Metabolic Disorders
Nat. Rev. Endocrinol. doi: /nrendo
Trachealess—A New Transcription Factor Target for PKB/Akt
The genetics of alcohol dependence and alcohol-related liver disease
Volume 18, Issue 1, Pages (July 2013)
Silencing Insulin Resistance through SIRT1
Marcelo O. Dietrich, Tamas L. Horvath  Trends in Neurosciences 
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
A Ceramide-Centric View of Insulin Resistance
Varman T. Samuel, Gerald I. Shulman  Cell Metabolism 
p38δ and PKD1: Kinase Switches for Insulin Secretion
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism  Barbara B. Kahn, Thierry Alquier, David Carling,
Volume 123, Issue 6, Pages (December 2002)
Vladimir Lizunov, Petr Chlanda, Mary Kraft, Joshua Zimmerberg 
Insulin Resistance in the Defense against Obesity
SOCS Proteins, Regulators of Intracellular Signaling
Fueling Up Skeletal Muscle to Reduce Obesity: A TrkB Story
Lost in Translation: An Antiviral Plant Defense Mechanism Revealed
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases  Jennifer W. Leiding, MD, Lisa.
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Cytokine Signaling Modules in Inflammatory Responses
IL-13 receptors and signaling pathways: An evolving web
Lipid Metabolism Greases the Stem Cell Engine
The Salt-Inducible Kinases: Emerging Metabolic Regulators
Volume 104, Issue 4, Pages (February 2001)
Volume 1, Issue 3, Pages (April 2002)
Lipid Sensing and Insulin Resistance in the Brain
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 
C16:0-Ceramide Signals Insulin Resistance
Volume 7, Issue 1, Pages 1-11 (July 1997)
Tackling Resistance to PI3K Inhibition by Targeting the Epigenome
Presentation transcript:

Protein Tyrosine Phosphatase 1B W.S. Cook, R.H. Unger  Developmental Cell  Volume 2, Issue 4, Pages 385-387 (April 2002) DOI: 10.1016/S1534-5807(02)00158-2

Figure 1 How PTP1B Affects Leptin Signaling (A) Depiction of the putative mechanism by which PTP1B causes resistance to leptin signaling believed to occur in diet-induced obesity. Although leptin binds normally to its cell surface receptor (1) and phosphorylates Jak2 (2), the receptor complex comes into proximity with PTP1B on the ER (3). There, PTP1B dephosphorylates Jak2, blocking the phosphorylation of the receptor and Stat3 (4). Unphosphorylated Stat3 is therefore unable to exert transcriptional control over its target genes that encode enzymes of lipid homeostasis. Consequently, ACC expression is abnormally high and CPT-1 is low (5); malonyl CoA levels are elevated and they inhibit CPT-1, thereby reducing oxidation of fatty acids (6). This is believed to lead to steatosis, lipotoxicity, and lipoapoptosis of nonadipocytes. (B) Depiction of mechanism of leptin sensitivity in PTP1B knockout mice. Steps (1) and (2) are presumably the same as in (A). However, PTP1B is absent and Stat3, phosphorylated by Jak2 (3), enters the nucleus to alter the transcription of its target genes (4). ACC and FAS are downregulated and CPT-1 and ACO are upregulated. The reduction of ACC expression, coupled with inactivation of the enzyme by AMP-activated kinase, a crucial control system not depicted here, reduces malonyl CoA activity and thereby disinhibits CPT-1 (5). Fatty acid synthesis is reduced, FA-CoA oxidation increases, and normal intracellular liporegulation is restored. ACC, acetyl CoA carboxylase; FAS, fatty acid synthase; CPT-1, carnitine palmitoyl transferase 1; ACO, acyl CoA oxidase; TG, triacylglycerol. (Figure by K. McCorkle.) Developmental Cell 2002 2, 385-387DOI: (10.1016/S1534-5807(02)00158-2)